PNPLA3 rs3747207位点多态性与NAFLD易感性的相关性
Correlation between PNPLA3 rs3747207 Polymorphism and Non-Alcoholic Fatty Liver Disease
DOI: 10.12677/ACM.2023.132274, PDF,   
作者: 孙田静, 辛永宁, 宣世英*:青岛大学附属青岛市市立医院感染性疾病科,山东 青岛;方海丽:青岛市第八人民医院感染性疾病科,山东 青岛;赵真真, 刘守胜:青岛大学附属青岛市市立医院临床研究中心,山东 青岛
关键词: 非酒精性脂肪性肝病基因多态性PNPLA3 rs3747207Non-Alcoholic Fatty Liver Disease Gene Polymorphism Patatin like Phospholipase Domain Containing Protein 3
摘要: 目的:探讨青岛地区汉族人群中patatin样磷脂酶结构域蛋白3 (Patatin-like phospholipase domain- containin, PNPLA3)基因rs3747207位点多态性与非酒精性脂肪性肝病(Non-Alcoholic Fatty Liver Disease, NAFLD)发病风险的相关性。方法:随机纳入2020年12月~2022年6月就诊于青岛市市立医院的NAFLD患者223例,并选取同期健康对照人群168例。采集所有受试者的临床数据及血液样本,检测血液样本的生物化学指标并测定PNPLA3 rs3747207位点基因型。根据是否符合正态分布对定量资料进行t检验或非参数检验。定性资料两组间比较采用χ2检验。采用二元logistic回归分析NAFLD发生的危险因素。结果:PNPLA3 rs3747207基因型分布及等位基因频率在NAFLD组和对照组之间分布无统计学意义(P均 > 0.05)。二元logistic回归分析表明,携带GG基因型未增加NAFLD发病风险(OR = 0.702, 95%CI: 0.428~1.152, P = 0.161)。GG基因型携带者低密度脂蛋白水平高于非携带者(P < 0.05)。结论:PNPLA3 rs3747207多态性与青岛地区汉族人群NAFLD发病风险无明显相关性。
Abstract: Objective: To investigate the relationship between PNPLA3 rs3747207 polymorphism and the on-set risk of non-alcoholic fatty liver disease in the Chinese Han population in Qingdao. Methods: A to-tal of 223 patients with NAFLD who attended Qingdao Municipal Hospital from December 2020 to June 2022 were enrolled in NAFLD group; 168 healthy individuals were enrolled in control group. We collected the clinical date and blood sample of all subjects to measure related biochemical pa-rameters and detect PNPLA3 rs3747207 genotype. The t-test was used for the comparison of nor-mally distributed quantitative data between two groups, and the non-parametric test was used for the non-normally distributed quantitative data between two groups. The chi-square test was used for comparison of qualitative data between two groups. The binary logistic regression analysis was used to investigate the risk factors for NAFLD. Result: There was no significant difference in PNPLA3 rs3747207 genotype distribution and allele frequency between the control group and NAFLD group (P > 0.05). The binary logistic regression analysis showed that the risk of NAFLD in individuals with genotype GG was not increased compared with those in individuals with allele gene A (OR = 0.702, 95%CI: 0.428~1.152, P = 0.161). For all subjects, the subjects with GG genotype had a higher level of low density lipoprotein than those with allele gene A (P < 0.05). Conclusion: There is no significant association between PNPLA3 rs3747207 polymorphism and the risk of NAFLD in the Chinese Han population in Qingdao.
文章引用:孙田静, 方海丽, 赵真真, 刘守胜, 辛永宁, 宣世英. PNPLA3 rs3747207位点多态性与NAFLD易感性的相关性[J]. 临床医学进展, 2023, 13(2): 1974-1981. https://doi.org/10.12677/ACM.2023.132274

参考文献

[1] Nassir, F. (2022) NAFLD: Mechanisms, Treatments, and Biomarkers. Biomolecules, 12, 824. [Google Scholar] [CrossRef] [PubMed]
[2] Riazi, K., Azhari, H., Charette, J.H., et al. (2022) The Prevalence and Incidence of NAFLD Worldwide: A Systematic Review and Meta-Analysis. The Lancet Gastroenterology and Hepa-tology, 7, 851-861. [Google Scholar] [CrossRef
[3] Yip, T.C., Lee, H.W., Chan, W.K., et al. (2022) Asian Per-spective on NAFLD-Associated HCC. Journal of Hepatology, 76, 726-734. [Google Scholar] [CrossRef] [PubMed]
[4] Estes, C., Razavi, H., Loomba, R., et al. (2018) Modeling the Epi-demic of Nonalcoholic Fatty Liver Disease Demonstrates an Exponential Increase in Burden of Disease. Hepatology, 67, 123-133. [Google Scholar] [CrossRef] [PubMed]
[5] Diaz, L.A., Arrese, M. and Arab, J.P. (2022) Hepatocellular Car-cinoma in Non-Alcoholic Fatty Liver Disease from a Clinical and Public Health Perspective. Hepatobiliary Surgery and Nutrition, 11, 755-758. [Google Scholar] [CrossRef] [PubMed]
[6] Juanola, O., Martinez-Lopez, S., Frances, R., et al. (2021) Non-Alcoholic Fatty Liver Disease: Metabolic, Genetic, Epigenetic and Environmental Risk Factors. International Jour-nal of Environmental Research and Public Health, 18, 5227. [Google Scholar] [CrossRef] [PubMed]
[7] Wong, W.K. and Chan, W.K. (2021) Nonalcoholic Fatty Liver Disease: A Global Perspective. Clinical Therapeutics, 43, 473-499. [Google Scholar] [CrossRef] [PubMed]
[8] Pingitore, P. and Romeo, S. (2019) The Role of PNPLA3 in Health and Disease. Biochimica et Biophysica Acta— Molecular and Cell Biology of Lipids, 1864, 900-906. [Google Scholar] [CrossRef] [PubMed]
[9] Romeo, S., Kozlitina, J., Xing, C., et al. (2008) Genetic Variation in PNPLA3 Confers Susceptibility to Nonalcoholic Fatty Liver Disease. Nat Genet, 40, 1461-1465. [Google Scholar] [CrossRef] [PubMed]
[10] Peng, X.E., Wu, Y.L., Lin, S.W., et al. (2012) Genetic Variants in PNPLA3 and Risk of Non-Alcoholic Fatty Liver Disease in a Han Chinese Population. PLOS ONE, 7, e50256. [Google Scholar] [CrossRef] [PubMed]
[11] Boonvisut, S., Yoshida, K., Nakayama, K., et al. (2017) Identi-fication of Deleterious Rare Variants in MTTP, PNPLA3, and TM6SF2 in Japanese Males and Association Studies with NAFLD. Lipids in Health and Disease, 16, 183. [Google Scholar] [CrossRef] [PubMed]
[12] Namjou, B., Lingren, T., Huang, Y., et al. (2019) GWAS and En-richment Analyses of Non-Alcoholic Fatty Liver Disease Identify New Trait-Associated Genes and Pathways across eMERGE Network. BMC Medicine, 17, 135. [Google Scholar] [CrossRef] [PubMed]
[13] Dwi Astarini, F., Ratnasari, N. and Wasityastuti, W. (2022) Up-date on Non-Alcoholic Fatty Liver Disease-Associated Single Nucleotide Polymorphisms and Their Involvement in Liver Steatosis, Inflammation, and Fibrosis: A Narrative Review. Iranian Biomedical Journal, 26, 252-268. [Google Scholar] [CrossRef] [PubMed]
[14] Gong, D., Li, S., Yu, Z., et al. (2022) Contribution of PNPLA3 Gene Pol-ymorphisms to Hepatocellular Carcinoma Susceptibility in the Chinese Han Population. BMC Medical Genomics, 15, 248. [Google Scholar] [CrossRef] [PubMed]
[15] National Workshop on Fatty Liver and Alcoholic Liver Disease, Chinese Society of Hepatology, Chinese Medical Association (2018) Guidelines of Prevention and Treatment for Nonal-coholic Fatty Liver Disease: A 2018 Update. Chinese Journal of Hepatology, 26, 195-203.
[16] Sharma, D. and Mandal, P. (2022) NAFLD: Genetics and Its Clinical Implications. Clinics and Research in Hepatology and Gastroenterology, 46, Article ID: 102003. [Google Scholar] [CrossRef] [PubMed]
[17] Xiang, H., Wu, Z., Wang, J., et al. (2021) Research Progress, Challenges and Perspectives on PNPLA3 and Its Variants in Liver Diseases. Journal of Cancer, 12, 5929-5937. [Google Scholar] [CrossRef] [PubMed]
[18] Ericson, E., Bergenholm, L. andreasson, A.C., et al. (2022) He-patic Patatin-Like Phospholipase Domain-Containing 3 Levels Are Increased in I148M Risk Allele Carriers and Correlate with NAFLD in Humans. Hepatology Communications, 6, 2689-2701. [Google Scholar] [CrossRef] [PubMed]
[19] He, S., Mcphaul, C., Li, J.Z., et al. (2010) A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis. Journal of Biological Chemistry, 285, 6706-6715. [Google Scholar] [CrossRef
[20] Shang, L. and Mashek, D.G. (2020) The Underpinnings of PNPLA3-Mediated Fatty Liver Emerge. Hepatology, 71, 375-377. [Google Scholar] [CrossRef] [PubMed]
[21] Kabbani, M., Michailidis, E., Steensels, S., et al. (2022) Human Hepatocyte PNPLA3-148M Exacerbates Rapid Non- Alcoholic Fatty Liver Disease Development in Chimeric Mice. Cell Reports, 40, Article ID: 111321. [Google Scholar] [CrossRef] [PubMed]
[22] Alam, S., Islam, M.S., Islam, S., et al. (2017) Association of Single Nucleotide Polymorphism at PNPLA3 with Fatty Liver, Steatohepatitis, and Cirrhosis of Liver. Indian Journal of Gastroenterology, 36, 366-372. [Google Scholar] [CrossRef] [PubMed]
[23] Chatterjee, A., Basu, A., Das, K., et al. (2021) Exome-Wide Scan Identifies Significant Association of rs4788084 in IL27 Promoter with Increase in Hepatic Fat Content among Indians. Gene, 775, Article ID: 145431. [Google Scholar] [CrossRef] [PubMed]
[24] Kallwitz, E.R., Tayo, B.O., Kuniholm, M.H., et al. (2019) Ameri-can Ancestry Is a Risk Factor for Suspected Nonalcoholic Fatty Liver Disease in Hispanic/Latino Adults. Clinical Gas-troenterology and Hepatology, 17, 2301-2309. [Google Scholar] [CrossRef] [PubMed]
[25] Seko, Y., Yamaguchi, K., Mizuno, N., et al. (2018) Combination of PNPLA3 and TLL1 Polymorphism Can Predict Advanced Fibrosis in Japanese Patients with Nonalcoholic Fatty Liver Disease. Journal of Gastroenterology, 53, 438-448. [Google Scholar] [CrossRef] [PubMed]
[26] Liu, W., An-stee, Q.M., Wang, X., et al. (2016) Transcriptional Regulation of PNPLA3 and Its Impact on Susceptibility to Nonalco-holic Fatty Liver Disease (NAFLD) in Humans. Aging (Albany NY), 9, 26-40. [Google Scholar] [CrossRef] [PubMed]
[27] Serper, M., Vujkovic, M., Kaplan, D.E., et al. (2020) Validating a Non-Invasive, ALT-Based Non-Alcoholic Fatty Liver Phenotype in the Million Veteran Program. PLOS ONE, 15, e0237430. [Google Scholar] [CrossRef] [PubMed]
[28] 陈霞. 低密度脂蛋白与糖尿病的关系[J]. 内科, 2012, 7(3): 304-306.
[29] Li, J., Zou, B., Yeo, Y.H., et al. (2019) Prevalence, Incidence, and Outcome of Non-Alcoholic Fatty Liver Disease in Asia, 1999-2019: A Systematic Review and Meta-Analysis. The Lancet Gastro-enterology and Hepatology, 4, 389-398. [Google Scholar] [CrossRef
[30] Zou, Y., Zhong, L., Hu, C., et al. (2021) LDL/HDL Choles-terol Ratio Is Associated with New-Onset NAFLD in Chinese Non-Obese People with Normal Lipids: A 5-Year Longi-tudinal Cohort Study. Lipids in Health and Disease, 20, 28. [Google Scholar] [CrossRef] [PubMed]
[31] Austin, M.A., Breslow, J.L., Hennekens, C.H., et al. (1988) Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction. JAMA, 260, 1917-1921. [Google Scholar] [CrossRef] [PubMed]
[32] Chatrath, H., Vuppalanchi, R. and Chalasani, N. (2012) Dyslipidemia in Patients with Nonalcoholic Fatty Liver Disease. Seminars in Liver Disease, 32, 22-29. [Google Scholar] [CrossRef] [PubMed]
[33] Speliotes, E.K., Massaro, J.M., Hoffmann, U., et al. (2010) Fatty Liver Is Associated with Dyslipidemia and Dysglycemia Independent of Visceral Fat: The Framingham Heart Study. Hepatology, 51, 1979-1987. [Google Scholar] [CrossRef] [PubMed]
[34] Siddiqui, M.S., Fuchs, M., Idowu, M.O., et al. (2015) Severity of Nonal-coholic Fatty Liver Disease and Progression to Cirrhosis Are Associated with Atherogenic Lipoprotein Profile. Clinical Gastroenterology and Hepatology, 13, 1000- 1008.e3. [Google Scholar] [CrossRef] [PubMed]
[35] Young Kim, S., Mun, S., Yu, J.H., et al. (2022) Association between Small Dense LDL Levels and Hepatic Fibrosis in Patients with Nonalcoholic Fatty Liver Disease. Medicine (Baltimore), 101, e30527. [Google Scholar] [CrossRef